trending Market Intelligence /marketintelligence/en/news-insights/trending/XdlayeDgbnLyTg15pB1G8Q2 content esgSubNav
In This List

Pike Street Capital buys US BioTek Laboratories

Podcast

Street Talk | Episode 94: Recessionary fears in '22 overblown, Fed could overtighten

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Pike Street Capital buys US BioTek Laboratories

Seattle-based private equity firm Pike Street Capital LLC paid an undisclosed sum to acquire US BioTek Laboratories Inc., which offers specialty testing services related to food allergies and intolerances to health and wellness professionals.

Shoreline, Wash.-based US BioTek will use the investment to expand and improve its testing and reporting capabilities, widen its customer base and hire new executives. US BioTek founders and leaders Raymond and Margaret Suen will transition to advisory roles but will remain investors in the company.

Pike Street manages a private equity fund that seeks growth buyouts in the lower-middle-market industrial technology sector.